Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease by Elhendy, A. (Abdou) et al.
Gender Differences in the Accuracy of
Dobutamine Stress Echocardiography for
the Diagnosis of Coronary Artery Disease
Abdou Elhendy, MD, PhD, Marcel L. Geleijnse, MD, Ron T. van Domburg, MSc,
Peter R. Nierop, MD, Don Poldermans, MD, PhD, Jeroen J. Bax, MD, PhD,
Folkert J. TenCate, MD, PhD, Youssef F.M. Nosir, MD, M. Mohsen Ibrahim, MD,
and Jos R.T.C. Roelandt, MD, PhD
The accuracy of dobutamine stress echocardiography
(DSE) for the diagnosis of coronary artery disease (CAD)
has not been yet evaluated in women. We studied the
effect of gender on the accuracy of DSE for the diagnosis
of CAD in 306 consecutive patients (210 men and 96
women) with limited exercise capacity and suspected
myocardial ischemia who underwent coronary angiog-
raphy within 3 months of DSE. There were no serious
complications during DSE. Men had a higher prevalence
of nonsustained ventricular tachycardia (7% vs 0.03%, p
<0.05) and supraventricular tachycardia (9% vs 0.03%,
p <0.05) during the test compared with women. Peak
stress rate–pressure product was not different in men
and women (18,140 6 4,187 vs 18,543 6 4,223).
Significant CAD (>50% luminal diameter stenosis) was
present in 171 men (81%) and in 62 women (65%, p
<0.005). The sensitivity, specificity, and accuracy of
ischemic pattern at DSE for the diagnosis of significant
CAD were 76% (confidence interval [CI] 67 to 84), 94%
(CI 89 to 99), and 82% (CI 75 to 90) in women and 73%
(CI 67 to 79), 77% (CI 71 to 83), and 74% (CI 68 to 80)
in men, respectively. Overall specificity was higher in
women than in men (p <0.05). Regional accuracy of
DSE was significantly higher in women than in men in
the 3 arterial regions (84% [CI 79 to 88] vs 75% [CI 72
to 79], p <0.005). It is concluded that DSE is a safe and
feasible method for the diagnosis of CAD in women. The
overall specificity and the regional accuracy of DSE are
higher in women than in men. Further studies are re-
quired to evaluate the functional significance of these
findings and their reproducibility in different patient
populations. Q1997 by Excerpta Medica, Inc.
(Am J Cardiol 1997;80:1414–1418)
Exercise echocardiography has been reported as anaccurate and cost-effective method for the diagno-
sis of coronary artery disease (CAD) in women.1–5 In
patients with limited exercise capacity, dobutamine
stress echocardiography (DSE) is a feasible alterna-
tive.6,7 The induction of myocardial ischemia at high-
dose dobutamine is due to an increase in myocardial
oxygen demand, and therefore the test is considered to
be a stress modality that simulates exercise.8,9 It may
be speculated that the high accuracy of exercise echo-
cardiography in women also applies to DSE. How-
ever, there are no data to prove this theory. In contrast,
it was reported that most of the false–positive DSE
tests occur in women.10 The aim of this study is to
determine if there is a gender difference in the accu-
racy of DSE for the diagnosis of CAD in patients with
limited exercise capacity undergoing DSE for evalu-
ation of myocardial ischemia.
METHODS
Patient population: The study population comprised
306 consecutive patients with limited exercise capac-
ity who underwent DSE for evaluation of myocardial
ischemia and coronary angiography within 3 months
from DSE. Mean age was 58 6 12 years. There were
210 men and 96 women; 214 patients (70%) had had
a previous myocardial infarction. Clinical characteris-
tics and reasons for stress testing in men and women
are shown in Table I. Among the 92 patients without
previous myocardial infarction, 5 women (11%) and 2
men (4%) had a low-pretest probability of CAD
(,10%), 25 women (56%) and 28 men (60%) had an
intermediate probability (10% to 80%), and 15 women
(33%) and 17 men (36%) had a high probability
(.80%) using specific calculations based on age, sex,
and chest pain characteristics reported by Diamond
and Forrester.11
Dobutamine stress test: Dobutamine was infused
through an antecubital vein starting at a dose of 5
mg/kg/min followed by 10 mg/kg/min (3-minute
stages) and increasing by 10 mg/kg/min every 3 min-
utes to a maximum of 40 mg/kg/min. Atropine (up to
1 mg) was given to patients not achieving 85% of age-
and gender-predicted maximum heart rate at peak
dobutamine dose.12 The test was interrupted if severe
chest pain, ST-segment depression .2 mm, signifi-
cant ventricular or supraventricular arrhythmia, hyper-
tension, a systolic blood pressure decrease .40 mm
Hg, or any intolerable side effect occurred during the
test. Ischemia during the electrocardiogram was de-
fined as $0.1 mV horizontal or downsloping ST-
segment depression 80 ms from the J point compared
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with baseline level or $0.1 mV ST-segment elevation
in electrocardiographic leads corresponding to seg-
ments without wall motion abnormalities at rest.13
Stress echocardiography: Echocardiographic im-
ages were acquired from standard views at rest and
during stress and recovery. The left ventricular wall
was divided into 16 segments and scored using a
4-point scale, where 1 5 normal, 2 5 hypokinesia,
3 5 akinesia, and 4 5 dyskinesia. Wall motion score
index was derived by dividing the sum of the score of
the 16 segments by 16. Ischemia was defined as new
or worsened wall motion abnormalities. Ischemia was
not considered if akinetic segments at rest became
dyskinetic during stress.14 The echocardiograms were
recorded on videotapes and digitized on optical disk
(Vingmed, CFM 800, Vingmed Sound A/S, Horten,
Norway). Images were compared side by side in quad-
screen format by 2 independent observers without the
knowledge of the patients’ gender, clinical, or angio-
graphic data. In case of disagreement, a majority de-
cision was achieved by a third investigator. The inter-
and intraobserver agreement for dobutamine stress
echocardiographic assessment in our laboratory were
91% and 92%, respectively.15
Coronary angiography: Coronary angiography was
performed within 3 months of DSE. Significant CAD
was defined as a diameter stenosis $50% in $1 major
epicardial arteries by the quantitative method de-
scribed previously.16 Coronary arteries were assigned
to myocardial segments as previously described.17 Be-
cause of the frequent vascular overlap in the posterior
and inferior walls, these 2 regions were assigned to
both the left circumflex and the right coronary ar-
teries.18
Statistical analysis: Unless specified, data are pre-
sented as mean values 6 SD. The chi-square test was
used to compare differences between proportions. The
Student’s t test was used for analysis of continuous
data. A p value ,0.05 was considered statistically
significant. Sensitivity, specificity, and accuracy were
derived according to the standard definitions and were
represented with 95% confidence intervals (95% CI).
RESULTS
The clinical characteristics of the subjects are
shown in Table I. Hemodynamic data are demon-
strated in Table II. Dobutamine–atropine induced a
significant increase in heart rate (p ,0.00001), sys-
tolic blood pressure (p ,0.0001), and rate–pressure
product (p ,0.00001) in men and women. Heart rate,
systolic blood pressure, and rate–pressure products
were not different between men and women at rest or
at peak stress. Women received a lower maximum
dose of dobutamine and received atropine less fre-
quently than men. Reasons for termination of the test
are listed in Table III. The target heart rate was
reached more frequently in women. The test was ter-
minated before reaching the maximum dose more
frequently in men because of the higher prevalence of
angina, ST-segment depression, and arrhythmias ne-
cessitating termination of the test in men. Side effects
and arrhythmias during the test are shown in Table IV.
Supraventricular and ventricular tachycardia occurred
more frequently in men. The incidence of hypotension
and other side effects was similar in men and women.
Coronary angiography: Significant CAD was de-
tected in 233 patients (76%). Ninety-one patients
(30%) had single-vessel CAD, 73 (24%) had 2-vessel
CAD, and 69 (23%) had 3-vessel CAD. Normal cor-
onary arteries or ,50% lesions were present in 73
patients (24%). Left anterior descending (LAD) cor-
onary artery stenosis was present in 164 patients
(54%), left circumflex (LCX) stenosis in 133 patients
(43%), and right coronary artery (RCA) stenosis in
147 patients (48%). Men had a higher prevalence of
CAD (81% vs 65%, p ,0.005) and multivessel CAD
(55% vs 27%, p ,0.00005).
Stress echocardiography: Wall motion score index
was higher in men than in women at rest (1.59 6 0.46
vs 1.40 6 0.46, p ,0.005) and at peak stress (1.76 6
0.53 vs 1.49 6 0.52, p ,0.0005). In patients without
previous myocardial infarction, the sensitivity, speci-
ficity, and accuracy of DSE in men were 72% (CI 59
to 85), 67% (CI 53 to 80), and 70% (CI 57 to 83). The
sensitivity, specificity, and accuracy in women were
74% (CI 61 to 87), 95% (CI 89 to 102, p ,0.05), and
84% (CI 74 to 95), respectively. In patients with
previous myocardial infarction, the sensitivity, speci-
ficity, and accuracy of DSE for the diagnosis of in-
farct-related artery stenosis in men were 64% (CI 56
to 71), 87% (CI 81 to 92), and 68% (CI 61 to 75); in
women these were 66% (CI 53 to 79), 94% (CI 87 to
101), and 75% (CI 63 to 86), respectively. Sensitivity,
specificity, and accuracy of DSE for the diagnosis of
remote coronary artery stenosis in men were 72% (CI
56 to 79), 80% (CI 74 to 86), and 75% (CI 68 to 82);
for women it was 75% (CI 63 to 87), 89% (CI 80 to
97), and 84% (CI 74 to 94), respectively. The sensi-
tivity, specificity, and accuracy of DSE for the overall
and regional diagnosis of CAD in all patients are
shown in Table V. Overall specificity of DSE was
higher in women (p 5 0.04). Regional accuracy was
higher in women than men in the LCX and RCA
regions (p ,0.05 in both) but not in the LAD region.
Regional accuracy of DSE in the 3 arterial regions
TABLE I Clinical Features of Men and Women Undergoing
Dobutamine–Atropine Stress Echocardiography
Clinical Features
Men
(n 5 210)
Women
(n 5 96) p Value
Age (yrs) 58 6 9 58 6 13 NS
Previous MI 163 (78) 51 (53) ,0.0001
Body weight (kg) 80 6 14 68 6 11 ,0.00001
Indications for stress testing
Typical chest pain 98 (47) 34 (35) 0.07
Atypical chest pain 51 (24) 37 (39) ,0.05
Routine post-MI assessment 36 (17) 13 (14) NS
To assess revascularization 25 (12) 12 (13) NS
Medications
b blockers 76 (36) 43 (45) NS
Calcium channel blockers 99 (47) 48 (50) NS
Nitrates 116 (55) 46 (48) NS
ACE inhibitors 98 (47) 27 (28) ,0.005
Data are expressed as mean 6 SD or number of patients (%).
ACE 5 angiotensin-converting enzyme; MI 5 myocardial infarction.
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pooled together was higher in women than in men (p
,0.005).
Comparison of echocardiography and electrocardi-
ography: Among 177 men with an interpretable elec-
trocardiogram, ischemic electrocardiographic changes
occurred in 58 of 144 patients with and in 5 of 33
patients without CAD (sensitivity 5 40% [CI 33 to
48], specificity 5 85% [CI 79 to 90], and accuracy 5
49% [CI 41 to 56]). Echocardiography
was more sensitive and accurate than
electrocardiography (p ,0.00001 for
both sensitivity and accuracy). Among
88 women with an interpretable elec-
trocardiogram, ischemic electrocardio-
graphic changes occurred in 16 of 57
patients with and in 6 of 31 patients
without significant CAD (sensitivity 5
28% [CI 19 to 37], specificity 5 81%
[CI 72 to 89], and accuracy 5 47% [CI
36 to 57], p 5 NS vs men). Echocar-
diography was more sensitive and ac-
curate than electrocardiography (p
,0.00001 for both sensitivity and ac-
curacy).
DISCUSSION
This is the first study that evalu-
ates the safety, feasibility, hemodynamic profile, and
accuracy of DSE for the diagnosis of CAD in women.
Our study shows that DSE is a feasible, safe, and
accurate method for the diagnosis of CAD in women
with limited exercise capacity and suspected myocar-
dial ischemia. There were no serious side effects dur-
ing the dobutamine stress test and the prevalence of
hypotension and minor side effects in women (dizzi-
ness, nausea, flushing, and headache) was similar with
those in men. Arrhythmias were not the reason for
termination of the test in any of the 96 women in-
cluded in this study. Additionally, the prevalence of
supraventricular and ventricular tachycardia was sig-
nificantly lower in women. This may be explained in
part by the lower prevalence of CAD and the better
baseline left ventricular function in women than in
men.
Gender differences in the accuracy of dobutamine
stress echocardiography: The higher overall specificity
and regional accuracy of DSE in women than in men
in our study is difficult to explain. A possible expla-
nation is the gender difference in the prevalence of
CAD.19 However, the lower prevalence of CAD in
women was not associated with reduced sensitivity.
Women have smaller left ventricular mass and wall
thickness than men.20 Myocardial regions adjacent to
the fibrous skeleton of the heart (the basal regions of
the posterior septum and the inferoposterior wall) may
demonstrate a heterogeneity of thickening at high-
dose dobutamine compared with adjacent caudal seg-
ments, giving a false–positive result in the absence of
significant coronary artery stenosis.10 Because men
have a thicker myocardium, this heterogeneity of
thickening may contribute to more false–positive tests
in men than in women in whom myocardial thickness
is less and heterogeneity of contraction between these
regions during stress may be less evident. Another
explanation is the less thick chest wall in women,
which may improve imaging compared with men. It
has been demonstrated that imaging quality influences
the agreement on interpretation of dobutamine stress
echocardiographic images21 and thereby may have an
effect on the accuracy of the test. Women reached the
TABLE II Hemodynamic Data of Men and Women Undergoing
Dobutamine–Atropine Stress Echocardiography
Hemodynamic and Stress
Test Variables
Men
(n 5 210)
Women
(n 5 96) p Value
Heart rate at rest (beats/min) 70 6 13 71 6 14 NS
Heart rate at peak stress (beats/min) 135 6 18 134 6 15 NS
Systolic blood pressure at rest
(mm Hg)
128 6 20 131 6 24 NS
Systolic blood pressure at peak stress
(mm Hg)
135 6 27 138 6 27 NS
Rate–pressure product at rest 9,021 6 2,394 9,406 6 2,991 NS
Rate–pressure product at peak stress 18,140 6 4,187 18,543 6 4,223 NS
Maximum dobutamine dose
(mg/kg/min)
38.4 6 74 36.9 6 7 0.03
Atropine given 113 (54) 39 (41) 0.03
ST-segment depression 63 (30) 22 (23) 0.2
Data are expressed as mean 6 SD or number of patients (%).
TABLE III Reasons for Termination of Dobutamine Stress
Testing in Men and Women
Reasons for Test
Termination
Men
(n 5 210)
Women
(n 5 96) p Value
85% of maximum heart
rate
137 (65) 81 (84) ,0.001
Maximum dose 21 (10) 3 (3) 0.03
Angina 29 (14) 7 (7) 0.1
ST changes 7 (3) 0 0.1
Arrhythmias 6 (3) 0 0.1
Hypotension 8 (4) 4 (4) NS
Chills, flushing, anxiety,
dizziness
2 (0.09) 1 (1.1) NS
Data are expressed as mean 6 SD or number of patients (%).
TABLE IV Symptoms and Complications of
Dobutamine–Atropine Stress Test in Men and Women
Symptoms
Men
(n 5 210)
Women
(n 5 96)
Nausea 4 (2) 5 (5)
Flushing 1 (0.5) 0
Dizziness 2 (1) 2 (2)
Anxiety 1 (0.5) 1 (1)
Chills 11 (5) 4 (4)
Headache 10 (5) 5 (5)
Symptomatic hypotension 1 (0.5) 1 (1)
Typical angina 92 (44) 36 (38)
SVT 18 (9) 2 (2)*
AF 1 (0.5) 0
VT ,10 beats 14 (7) 1 (1)*
VT .10 beats 1 (0.5) 0
*p ,0.05.
AF 5 atrial fibrillation; SVT 5 supraventricular tachycardia; VT 5 ventricular
tachycardia.
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target heart rate more often than men. This may ex-
plain the higher regional accuracy of DSE in women
than in men. Finally, an intrinsic gender difference in
myocardial response to dobutamine infusion may ex-
ist. Women may have a better response to the same
dose of dobutamine than men due to a difference in
the volume of distribution. In this study, women could
reach the target heart rate more frequently and re-
quired atropine administration less frequently than
men despite the relatively higher prevalence of ther-
apy with b blockers and the smaller peak dobutamine
dose in women.
Comparison with previous studies: Bach et al10 re-
ported that most of the false–positive DSE studies
occurred in women. However, these authors did not
report the prevalence of CAD in their study. There-
fore, gender difference in the specificity of DSE could
not be studied due to the lack of information regarding
the true negative tests. The results of our study are
aligned with previous reports, which inferred the use-
fulness of stress echocardiography for the diagnosis of
CAD in women.1–3,22 Massini et al22 studied the ac-
curacy of high-dose dipyridamole echocardiography
in 83 women with a 47% prevalence of CAD. Echo-
cardiography had a sensitivity of 79% and a specificity
of 93%. Marwick et al3 reported that in 161 women
with a 63% prevalence of CAD, exercise echocardi-
ography had a sensitivity of 80% and specificity of
81%. Roger et al23 compared the diagnostic accuracy
of exercise echocardiography in men and women with
suspected CAD. They concluded that in clinical prac-
tice, test verification bias in angiographic referrals
results in a lower observed specificity and a higher
sensitivity of exercise echocardiography. The positive
predictive value and adjusted sensitivity were lower in
women compared with men and the authors concluded
that the difference may represent an intrinsic gender
difference rather than being related to gender differ-
ence in the prevalence of the diseases.
Study limitations: Most of the study patients had a
previous myocardial infarction and the prevalence of
CAD was high. Therefore, these patients represent the
usual patients selected for coronary angiography
rather than the overall population subjected to nonin-
vasive testing as has been demonstrated in studies of
exercise echocardiography.23 It is important to con-
duct a similar study in a large group of patients with
suspected CAD, particularly in those with the inter-
mediated probability of CAD. Nevertheless, the trend
to better specificity and accuracy of DSE in women
than in men was also demonstrated in patients without
previous myocardial infarction in our study. Men and
women were not matched with regard to the preva-
lence of CAD and left ventricular function at rest.
Referral bias in performing coronary angiography
may have contributed to differences in diagnostic ac-
curacy.23 However, the higher specificity of DSE in
women was coupled with a high-positive predictive
value despite a lower prevalence of CAD in women,
which suggests an intrinsic gender difference in the
response to dobutamine rather than a difference in the
clinical characteristic or referral bias as the underlying
reason for gender difference in specificity and regional
accuracy.
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